BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 29434450)

  • 21. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
    Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
    Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
    Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
    World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma in HIV hepatitis C virus.
    Puoti M; Rossotti R; Garlaschelli A; Bruno R
    Curr Opin HIV AIDS; 2011 Nov; 6(6):534-8. PubMed ID: 21934618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
    Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
    Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of viral hepatitis and hepatocellular carcinoma.
    El-Serag HB
    Gastroenterology; 2012 May; 142(6):1264-1273.e1. PubMed ID: 22537432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
    Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus and hepatitis C virus dual infection.
    Caccamo G; Saffioti F; Raimondo G
    World J Gastroenterol; 2014 Oct; 20(40):14559-67. PubMed ID: 25356020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.
    Huang AJ; Núñez M
    J Int Assoc Provid AIDS Care; 2015; 14(4):360-8. PubMed ID: 25999329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
    Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
    J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?
    Saud LRC; Chagas AL; Maccali C; Pinto PVA; Horvat N; Alencar RSSM; Tani CM; Abdala E; Carrilho FJ
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):583-588. PubMed ID: 33560682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HBV and HCV coinfections in children--own investigations].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.